SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25137169 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Franca Orsini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, MI, Italy. Hauptthemen laut MEDLINE: tau Proteins, Sumoylation, Hippocampus, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Alzheimer's Association, Alzheimer’s Association Research Grant.
Abstract (Originalsprache)
Neurologic manifestations are an immediate consequence of SARS-CoV-2 infection, the etiologic agent of COVID-19, which, however, may also trigger long-term neurological effects. Notably, COVID-19 patients with neurological symptoms show elevated levels of biomarkers associated with brain injury, including Tau proteins linked to Alzheimer’s pathology. Studies in brain organoids revealed that SARS-CoV-2 alters the phosphorylation and distribution of Tau in infected neurons, but the mechanisms are currently unknown. We hypothesize that these pathological changes are due to the recruitment of Tau into stress granules (SGs) operated by the nucleocapsid protein (NCAP) of SARS-CoV-2. To test this hypothesis, we investigated whether NCAP interacts with Tau and localizes to SGs in hippocampal neurons in vitro and in vivo. Mechanistically, we tested whether SUMOylation, a posttranslational modification of NCAP and Tau, modulates their distribution in SGs and their pathological interaction. We found that NCAP and Tau colocalize and physically interact. We also found that NCAP induces hyperphosphorylation of Tau and causes cognitive impairment in mice infected with NCAP in their hippocampus. Finally, we found that SUMOylation modulates NCAP SG formation in vitro and cognitive performance in infected mice. Our data demonstrate that NCAP induces Tau pathological changes both in vitro and in vivo. Moreover, we demonstrate that SUMO2 ameliorates NCAP-induced Tau pathology, highlighting the importance of the SUMOylation pathway as a target of intervention against neurotoxic insults, such as Tau oligomers and viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milano, MI, Italy.
- Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 2S8, Canada.
- Department of Pathology and Cell Biology, Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY 10032, USA.
ORCID-Profile: Franca Orsini, Davide Comolli, Ottavio Arancio, Luana Fioriti
Förderung
- NINDS NIH HHS
- Alzheimer's Association
- Alzheimer’s Association Research Grant
- Alzheimer’s Association Research Fellowship
Zitieren
APA
Orsini, F., Bosica, M., Martucci, A., De Paola, M., Comolli, D., Pascente, R., Forloni, G., Fraser, P. E., Arancio, O., & Fioriti, L. (2024). SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25137169
Vancouver
Orsini F, Bosica M, Martucci A, De Paola M, Comolli D, Pascente R, et al. SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25137169
BibTeX
@article{Orsini2024,
author = {Orsini, Franca and Bosica, Marco and Martucci, Annacarla and De Paola, Massimiliano and Comolli, Davide and Pascente, Rosaria and Forloni, Gianluigi and Fraser, Paul E and Arancio, Ottavio and Fioriti, Luana},
title = {SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25137169}
}
EUVIMED